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Abstract
Genome-scale metabolic models (GEMs) are widely used to
calculate metabolic phenotypes. They rely on defining a set of
constraints, the most common of which is that the production
of metabolites and/or growth are limited by the carbon source
uptake rate. However, enzyme abundances and kinetics, which
act as limitations on metabolic fluxes, are not taken into
account. Here, we present GECKO, a method that enhances a
GEM to account for enzymes as part of reactions, thereby ensur-
ing that each metabolic flux does not exceed its maximum
capacity, equal to the product of the enzyme’s abundance and
turnover number. We applied GECKO to a Saccharomyces cere-
visiae GEM and demonstrated that the new model could
correctly describe phenotypes that the previous model could
not, particularly under high enzymatic pressure conditions, such
as yeast growing on different carbon sources in excess, coping
with stress, or overexpressing a specific pathway. GECKO also
allows to directly integrate quantitative proteomics data; by
doing so, we significantly reduced flux variability of the model,
in over 60% of metabolic reactions. Additionally, the model gives
insight into the distribution of enzyme usage between and
within metabolic pathways. The developed method and model
are expected to increase the use of model-based design in
metabolic engineering.
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Introduction
Metabolism is at the core of cellular function; the development of
reliable quantitative models of metabolism is thus a main objective
of systems biology. For the past 20 years, a recurrent modeling
approach for reaching this objective has been constraint-based
modeling (Lewis et al, 2012; Palsson, 2015), which enables calcula-
tion of metabolic fluxes from reactions’ stoichiometry and intracel-
lular metabolites’ mass balances. Genome-scale models (GEMs),
which are genome-wide constraint-based models, have been used
extensively for metabolic engineering applications such as yield or
knockout predictions (Kerkhoven et al, 2014; O’Brien et al, 2015).
However, when considering the production of a metabolite of inter-
est, these models typically make the assumption that the uptake rate
of the carbon source (e.g., glucose) limits production. This may be
an oversimplification, as metabolic fluxes are limited by their corre-
sponding enzyme levels. However, this cannot be directly tested in
traditional GEMs because they do not allow for connecting enzyme
concentrations to metabolic fluxes. Therefore, there is interest in
developing novel modeling concepts that will enable the incorpora-
tion of enzyme levels in GEMs, particularly as quantitative proteo-
mics data, from which enzyme levels can be inferred, become more
available. Proteomics data have so far mostly been indirectly
combined with GEMs by correlating protein levels to the corre-
sponding fluxes (Sa´nchez & Nielsen, 2015).
Different approaches have been developed to account for enzy-
matic limitations in metabolic models. One approach, flux balance
analysis with molecular crowding (FBAwMC) (Beg et al, 2007),
relies on imposing a global capacity constraint on the total cellular
volume occupied by all metabolic enzymes. The approach has also
been adapted to constrain the total mass of the enzymes (Shlomi
et al, 2011). Using FBAwMC together with a GEM of Escherichia
coli, it was shown that acetate production at a high specific growth
rate is due to the low catalytic efficiency of oxidative phosphoryla-
tion (Beg et al, 2007; Vazquez et al, 2008). Similar results were
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observed using variations of the approach in lactate-producing
cancerous human cells (the Warburg effect) (Shlomi et al, 2011;
Vazquez & Oltvai, 2011) and in ethanol-producing Saccharomyces
cerevisiae cells (the Crabtree effect) (Van Hoek & Merks, 2012;
Nilsson & Nielsen, 2016). Other variations of the approach have
been developed to consider enzymes as a separate entity (Adadi
et al, 2012) and to account for additional protein sectors (Mori et al,
2016). Nonetheless, these approaches were developed to study the
global adaptation of the proteome to physiochemical constraints
and are hence not designed for the integration of proteomic data.
An alternative framework to account for enzyme limitation is a
genome-scale model of both metabolism and gene expression (ME
model) (O’Brien & Palsson, 2015), which includes metabolic reac-
tions and all processes required for the synthesis of functional
proteins starting from the transcription rates of genes. This
approach has been used to confirm a limitation in enzyme capac-
ity at a high specific growth rate in E. coli (O’Brien et al, 2013).
ME models have only been developed for Thermotoga maritima
(Lerman et al, 2012) and E. coli (Orth et al, 2010) because they
require detailed knowledge of all the steps of protein synthesis
(protein maturation, protein folding, metal binding, etc.), which
are not readily available for all organisms, and in particular for
eukaryal cells. Although there have been recent efforts in model-
ing the protein secretion process in those organisms (Feizi et al,
2013; Liu et al, 2014b), details of the protein synthesis
requirements are needed, especially in terms of localization and
compartmentalization.
Alternative approaches such as resource balance analysis
(Goelzer et al, 2015), self-replicating models (Molenaar et al, 2009;
Berkhout et al, 2013), and whole-cell models (Karr et al, 2012) have
also been developed to account for protein limitations. The former
estimates apparent catalytic rates from experimental data and uses
the estimations as hard constraints (equalities) to predict protein
distribution; therefore, it requires multiple experimental datasets.
The latter two approaches either are mostly qualitative in nature or
require an excessive number of parameters that are not currently
available. Considering all aforementioned modeling approaches, a
quantitative predictive genome-scale method is needed that can
impose soft constraints (inequalities) on each enzyme level for inte-
gration of proteomics data.
Here, we present a comprehensive modeling approach for using
enzyme kinetics and abundances to constrain a GEM to biologically
feasible fluxes. In our methodology, each metabolic reaction
includes an extra entity that represents enzyme usage. The entity is
limited by the protein abundance, which can be provided as input
to the model. Thus, we can conveniently simulate metabolism with
constraints based on protein abundance measurements, correctly
representing capacity constraints on fluxes. The method enhances a
GEM with Enzymatic Constraints using Kinetic and Omics data and
is referred to as GECKO. We applied GECKO to a GEM of S. cere-
visiae and show how different biological phenomena can be
explained with the approach. In particular, through simulation, we
show that enzyme limitation governs different cellular behaviors,
such as gene knockout phenotype, growth on different carbon
sources, and yields of secreted metabolites. These results reinforce
the idea that there is a simple principle for protein allocation in
microorganisms (Basan et al, 2015; Hui et al, 2015; Nilsson &
Nielsen, 2016).
Results
GECKO: accounting for enzyme constraints in a genome-
scale model
Any reaction flux (or metabolic rate) has a basic constraint: The flux
cannot exceed the reaction’s maximum rate (vmax), which is equal
to the intracellular concentration of the corresponding enzyme
multiplied by the enzyme’s turnover number (kcat value). However,
intricate relationships between enzymes and reactions are quite
frequent and complicate the aforementioned constraint (Adadi et al,
2012). Examples of this include isozymes, i.e., different enzymes
that catalyze the same reaction; promiscuous enzymes, which can
catalyze different reactions; complexes, in which several subunits
together catalyze one reaction; and reversible reactions, where an
enzyme catalyzes both directions of the same reaction.
We developed GECKO to limit metabolic fluxes in any GEM with
enzymatic data in a simple manner, so we can reduce the variability
of constraint-based modeling results and improve predictions. The
approach extends genome-scale modeling by representing enzymes
as entities with limited capacities in the corresponding reactions in
the model (Fig 1A). In traditional genome-scale modeling, a stoi-
chiometric matrix representing the whole metabolism is defined in
which columns indicate each reaction’s stoichiometry, and rows
indicate the mass balance for each metabolite. In GECKO, we
expanded the approach by adding new rows to this matrix that
represent the enzymes and new columns that represent each
enzyme’s usage (Fig 1B; Gu et al, 2016; Machado et al, 2016).
Kinetic information, in the form of kcat values, is included as
stoichiometric coefficients to convert the metabolic flux in
mmol gDWh1 to the required enzyme usage in mmol gDW1. The
protein level is included as an upper bound for each enzyme usage;
thus, the desired constraint on each flux is respected (Fig 1B).
All enzymes in the model were inferred using the GEM’s gene
associations and querying SWISS-PROT (Boeckmann et al, 2003)
and KEGG (Kanehisa & Goto, 2000). Specific formalisms were devel-
oped to manage cases such as reversible enzymes, isozymes,
promiscuous enzymes, and complexes. Turnover numbers were
automatically queried from BRENDA (Schomburg et al, 2013) with
flexible criteria to manage the high data variability. Enzyme abun-
dances can be set in the model as upper bounds according to experi-
mental values (absolute proteomics). In the absence of proteomic
data (or incomplete data), enzyme-specific constraints can be
replaced with a total enzyme mass constraint, similar to the
FBAwMC approach (Beg et al, 2007). For additional details of
GECKO, see the Materials and Methods section.
ecYeast7: an enzyme-constrained model of
Saccharomyces cerevisiae
General description of the model
GECKO was applied to the latest version of the consensus genome-
scale reconstruction of yeast (Aung et al, 2013), Yeast7, which
currently consists of 3,493 reactions and 2,220 metabolites. The
resulting enzyme-constrained model, hereafter referred to as
ecYeast7, has 6,741 reactions and 3,388 metabolites, of which 764
are enzymes and 404 are pseudo-metabolites introduced to manage
isozymes (Table 1). Intricate relationships between enzymes and
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reactions are common in the model, with 226 complexes, 373 reactions
with isozymes and 315 promiscuous enzymes (Table 1, Appendix Fig
S2). Additionally, we can see that enzymes in the cytoplasm, mito-
chondrion, and endoplasmic reticulum are the most numerous
(Fig 2A). Finally, ecYeast7 is fully compatible with the COBRA toolbox
(Schellenberger et al, 2011) and has similar simulation running times
compared to its metabolic counterpart: A standard growth maximiza-
tion FBA problem of ecYeast7 is solved in 135  7.3 ms with the
Gurobi LP solver in a Windows PC with a 2.1 GHz Intel i7-4600U two
processor, compared to 138  9.7 ms in the case of Yeast7.
Biochemical characteristics of enzymes in the model
Next, we investigated the biochemical properties, namely kcat values
and molecular weights, of the 764 enzymes in ecYeast7. We found
that molecular weights spanned 3 orders of magnitude and kcat
values spanned 11 orders of magnitude, with median values of
48.2 kDa and 70.9 s1, respectively (Appendix Fig S3). In total,
92.1% of the kcat values were between 0.1 and 10,000 s
1, that is,
six orders of magnitude (Fig 2B). It should be considered that values
in the BRENDA database are typically measured in vitro and may
thus differ from the in vivo values to some extent.
We then compared enzymes among different metabolic functions
by classifying them into three different metabolic groups: (i) carbohy-
drate and energy primary metabolism; (ii) amino acid, fatty acid, and
nucleotide primary metabolism; and (iii) intermediate and secondary
metabolism (see the Materials and Methods section). Different meta-
bolic groups had different kcat value (Fig 2B) and molecular weight
(Fig 2C) distributions. In particular, the carbohydrate and energy
primary metabolism enzymes had markedly higher kcat values (me-
dian = 120 s1) and lower molecular weights (median = 41.7 kDa)
than the other two groups; that is, they were faster in catalysis and
smaller. Conversely, the intermediate and secondary metabolism
enzymes were slower in catalysis (median kcat value = 45.1 s
1) and
larger (median molecular weight = 53.6 kDa). Finally, amino acid,
fatty acid, and nucleotide primary metabolism enzymes had inter-
mediate kcat values (median = 65.9 s
1) and molecular weights
(median = 47.1 kDa). This is in agreement with previous observations
(Bar-Even et al, 2011) that identified central carbon metabolism
enzymes as the most efficient in metabolism, most likely due to evolu-
tionary pressure on this part of metabolism to operate with high fluxes.
We also compared biochemical properties across different types
of enzymes, that is, complexes, isozymes, and promiscuous
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Figure 1. Framework for including enzymes as metabolites in a genome-scale model.
A GECKO uses a genome-scale model and includes enzymes as part of reactions.
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enzymes (Appendix Figs S4 and S5). We observed that proteins that
belong to complexes are significantly faster (Appendix Fig S4B) and
smaller (Appendix Fig S5B) than stand-alone enzymes and that
promiscuous enzymes are faster (Appendix Fig S4D) than non-
promiscuous enzymes.
Connectivity of the model
Connectivity metrics for Yeast7 and ecYeast7 were computed using
the metabolite network (Table 2), with and without currency
metabolites such as ATP and NADH (see Appendix for more
details). Overall, we observed similar values, indicating that the
enzyme-constrained model has similar topology to that of the origi-
nal model. Among the observed differences, the global clustering
coefficient and the average betweenness centrality were lower for
ecYeast7. This indicates that the enzyme-constrained network is less
clustered, which is mainly due to the inclusion of 404 pseudo-meta-
bolites as intermediate steps in reactions with isozymes. Conversely,
the average local clustering coefficient is higher than that of Yeast7,
which indicates an increase in local clusters. This is consistent with
the observed increase in node degree, both in the average (Table 2)
and overall distributions (Appendix Fig S6), and is mainly due to
the addition of 764 enzymes, which leads to new connections to
most metabolites in the network, or several in the case of isozymes.
Simulating physiological behavior
First, the model was tested without the input of proteomics data.
Only a constraint with the total amount of enzyme (g gDW1) was
applied, and the model was allowed to freely allocate the enzymes
within this overall constraint. This was performed using a module
of GECKO that introduces a pseudo-metabolite that acts as an
enzyme pool (see the Materials and Methods section), creating a
total mass constraint similar to the molecular crowding formalism
(Beg et al, 2007; Adadi et al, 2012). With this approach, we tested a
series of physiological responses including overflow metabolism,
stress response, and consumption of non-typical carbon sources.
Growth at increasing specific growth rate: simulating the
Crabtree effect
Overflow metabolism occurs in several organisms, including E. coli
(Van Hoek & Merks, 2012), S. cerevisiae (Van Hoek et al, 1998), and
cancer cells (Vazquez & Oltvai, 2011). In the case of S. cerevisiae, it
is known as the Crabtree effect; under aerobic conditions at a critical
specific growth rate of approximately 0.3 h1 [a value that is strain-
dependent (Van Dijken et al, 2000)], yeast metabolism switches
from purely respiratory to a combination of respiration and
fermentation resulting in the production of ethanol, which is less
energetically efficient.
There are numerous theories concerning the cause of overflow
metabolism (Molenaar et al, 2009); recently, it was suggested that
protein limitation may be the underlying reason. Faster growth
requires more energy and thus higher metabolic fluxes, which
requires more enzyme mass. However, the protein pool inside the
cell is limited, and respiration enzymes, the main energy generators
in the cell, have low specific activity due to their large size. Thus, the
cell switches to a more mass efficient protein composition when the
specific growth rate surpasses a certain threshold. This composition
accounts for pathways that can produce more ATP with the same
amount of enzyme mass, even though they have a lower ATP/
carbon yield. This has been shown with different approaches in a
self-replicator model (Molenaar et al, 2009; Berkhout et al, 2013),
E. coli (Vazquez et al, 2008; O’Brien et al, 2013; Basan et al, 2015;
Peebo et al, 2015), cancer cells (Shlomi et al, 2011; Vazquez &
Oltvai, 2011), and S. cerevisiae (Van Hoek & Merks, 2012; Nilsson &
Nielsen, 2016). However, the concept has not been tested for S. cere-
visiae at the genome-scale using real kinetic values.
Traditional GEMs are unable to show overflow metabolism
unless ad hoc constraints or objective functions are imposed (Famili
et al, 2003); therefore, we tested whether ecYeast7 shows this meta-
bolic shift at increasing specific growth rates due to the total enzyme
mass constraint. Assuming an average enzyme saturation of 51%,
we attained a good fit to experimental data from the literature (Van
Hoek et al, 1998; Fig 3A), and we observed a region of dual limita-
tion in glucose and enzyme content for dilution rates above 0.3 h1,
a region that has been referred to as the Janusian region (O’Brien
et al, 2013), in which a switch from respiration toward fermentation
occurs. As expected, the original Yeast7 model was not able to
reproduce this behavior (Appendix Fig S7), and although an
enzyme-constrained model with randomly assigned kcat values or
molecular weights did occasionally show it (Appendix Fig S8), more
than 99.9% of the time the shift was predicted at lower dilution
rates. Therefore, we can corroborate that the Crabtree phenotype is
an adaptation to the enzyme properties and not a network property
(Nilsson & Nielsen, 2016). Additionally, we also see a small Janu-
sian region at high growth rates during anaerobic conditions (Nissen
et al, 1997; Fig 3D), which shows a slight tradeoff between the
ethanol and glycerol production rates.
When investigating the enzyme usage predictions at increasing
specific growth rate under aerobic conditions (Fig 3B), we see that
Table 1. Descriptors of ecYeast7, the Saccharomyces cerevisiae model
expanded to account for enzymes.
General descriptors of the model
Number of reactions 6,741
Number of metabolites 3,388
Number of compartments 14
Classification of reactions
Metabolic reactions matched with an enzyme(s) 3,239
Metabolic reactions not matched with an enzyme 330
Transport reactions 1,674
Metabolite exchange reactions 330
Arm reactions introduced for isozymes 404
Enzyme usages (treated as reactions) 764
Classification of metabolites
Original metabolites 2,220
Enzymes 764
Pseudo-metabolites introduced for isozymes 404
Enzyme/reaction relationships
Complexes 226
Reactions with isozymes 373
Promiscuous enzymes 315
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above the critical specific growth rate (0.3 h1), enzymes from the
oxidative phosphorylation pathway (the most mass intensive path-
way) are progressively replaced by increased abundance of glyco-
lytic enzymes. This supports the view that energy synthesis in
yeast is dominated by two strategies: metabolic efficiency at low
specific growth rate and catalytic efficiency at high specific growth
rate (Molenaar et al, 2009; Nilsson & Nielsen, 2016). Notably, the
saturation rather than the concentration could decrease for
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Figure 2. Visualization of the Saccharomyces cerevisiae model expanded to account for enzymes.
A Network with metabolites and enzymes, color-coded to show the location of enzymes (green dots) and metabolites (color-coded by compartment).
B, C Cumulative distributions of (B) kcat values and (C) molecular weights for three different metabolic groups. All distributions were significantly different with P < 0.05
using a non-parametric Wilcoxon rank-sum test (Appendix Table S4).
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oxidative phosphorylation enzymes and increase for glycolytic
enzymes (Van Hoek et al, 1998, 2000). This distinction is outside
the scope of our simulations as we assumed an average saturation
among enzymes due to the lack of enzyme-specific saturation data
in the literature. Although models that use the overall mass
constraint concept have shown to be predictive of protein content
to some extent (Nilsson & Nielsen, 2016), good quality genome-
scale proteomic datasets of yeast are needed to confirm whether
the aforementioned enzyme tradeoffs are related to saturation,
concentration or both.
We also investigated whether simulation variability was altered
when the enzyme mass constraint was used. We performed flux
variability analysis (FVA) (Mahadevan & Schilling, 2003) on the
original Yeast7 model and the new ecYeast7 (see Appendix for more
details and Appendix Fig S9 for detailed results at different specific
growth rates). From the analysis, we see that only a small fraction
of the fluxes increased their variability, whereas most of the fluxes
either maintained or reduced their variability (Fig 3C). We also see
that, up to the critical specific growth rate, between 30 and 40% of
the fluxes have a reduced variability when accounting for enzyme
constraints, and this increases to over 60% when the enzyme limita-
tion is reached. Overall, we conclude that by accounting for a total
enzyme mass constraint in GEMs, we can decrease the intrinsic vari-
ability of the model to a large extent.
Growing under temperature stress
Overflow metabolism in yeast occurs not only at high specific
growth rates but also under stress conditions in which high amounts
of energy are needed. We simulated stress at high temperatures by
increasing the non-growth associated maintenance (NGAM) so that
the model would fit experimental data (Lahtvee et al, 2016) of a
glucose-limited chemostat operated at 0.1 h1 and 38°C, for both
Yeast7 and ecYeast7 (Fig 3E). By including enzyme constraints, our
model showed secretion of ethanol and a corresponding increased
glucose consumption as well as decreased oxygen consumption,
features that are not seen when using the original model (Fig 3E)
nor the unmodified NGAM (Appendix Fig S10).
Maximum growth under different carbon sources
Finally, we tested ecYeast7 to describe aerobic, non-restricted
growth on three different media (minimal, with amino acids, or
complex) and 12 different carbon sources, and compared the
results with literature studies (Tyson & Lord, 1979; Van Dijken
et al, 2000). Using an average enzyme saturation of 44%, value
estimated by fitting the model to growth on glucose, we were able
to successfully reproduce the maximum specific growth rate for
most conditions (Fig 4B, average relative error of 8% with a P-
value < 0.001 when comparing the results to models with random-
ized kcat values). For comparison, we calculated how much growth
the purely metabolic model predicted under the same conditions;
for this purpose, upper bounds were imposed on all uptake rates
based on the results from the enzyme-constrained model, given
that unlimited uptake rate leads to unlimited growth in a purely
metabolic model. It can be observed that Yeast7 still widely over-
predicted growth (Fig 4A, average relative error of 100%), showing
that the enzyme constraint can explain the maximum specific
growth rate under many different conditions, without any specifi-
cation of uptake fluxes.
Notably, there was a significantly improved prediction by
ecYeast7 for growth on sucrose. Yeast7 predicted a much faster
growth on sucrose than growth on glucose (Fig 4A). This is
expected because the purely metabolic model will metabolize both
glucose and fructose molecules present in sucrose. Interestingly,
when simulating with ecYeast7, the specific growth rates on glucose
and sucrose are equal (Fig 4B) and in good agreement with those
experimentally observed. We examined the flux exchange rates and
noticed that none of the fructose content in sucrose is used by
ecYeast7, because of the ATP cost associated with fructose uptake.
Therefore, to grow optimally with a limited enzyme pool, the cell
chooses to utilize the most efficient carbon source, glucose. This is
in accordance with the observed in vivo behavior of monosaccha-
ride accumulation during sucrose consumption (D’Amore et al,
1989) and benchmarks the predictive power of our model. Conver-
sely, trehalose stands out as the worst prediction with the enzyme-
constrained model (Fig 4B). The model computes a much higher
specific growth rate than that observed experimentally, most likely
due to the high hydrated volume of trehalose (Sola-Penna & Meyer-
Fernandes, 1998), which reduces protein activity, thereby hindering
amino acid/nucleotide uptake, a process that is not captured by our
model.
We also compared all of the flux distributions using principal
component analysis (PCA). We see that flux simulations from Yeast7
are quite similar among them, with more than 97% of the variability
explained with only one component and clustering mainly depend-
ing on the specific growth rate (Fig 4C). This indicates that, to a
large extent, flux simulations from the purely metabolic model are
equivalent but scaled by the specific growth rate. In contrast, simula-
tions of ecYeast7 have more diversity (the first two components
comprise ~87% of the variability) and are clustered based on the
carbon source; for instance, all three glucose flux distributions are
close together (Fig 4D). Furthermore, the flux distributions of
non-fermentable carbon sources (ethanol, acetate, glycerol, and
galactose) clustered together, pinpointing that similar metabolic
Table 2. Connectivity metrics with and without currency metabolites,
computed for both the original metabolic model and the enzyme-
constrained model.
Metric
Full matrix
With no currency
metabolites
Yeast7 ecYeast7 Yeast7 ecYeast7
Global
clustering coefficient
0.09 0.06 0.24 0.06
Average local
clustering coefficient
0.58 0.63 0.41 0.56
Average
node degree
13.3 13.7 8.2 9.1
Characteristic
path length
3.4 3.4 4.6 5.1
Diameter 8 9 17 17
Average
path diversity
9.8 10.1 12.3 41.4
Average
betweenness
centrality
1.1E-03 7.2E-04 2.0E-03 1.3E-03
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Figure 3. The limited enzyme supply defines yeast metabolic strategies at high energy demand in glucose-limited cultures.
A Chemostat aerobic data and model simulations at increasing dilution rate.
B Predicted top 6 pathways used in terms of mass at increasing dilution rate in aerobic conditions.
C Reduced flux variability compared with purely metabolic GEM simulations at increasing dilution rate in aerobic conditions.
D Chemostat anaerobic data and model simulations at increasing dilution rate.
E The model chooses to ferment when energy requirements for non-growth maintenance are high. Experimental data (mean  SD) were taken from biological
triplicates of S. cerevisiae grown at high temperature (Lahtvee et al, 2016).
Data information: The light blue areas in (A–D) denote the dual-limitation (Janusian) region.
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pathways were used in these cases. These observations suggest that
the carbon source (main substrate present) plays a more important
role in defining the metabolic profile compared to the media type
(additional substrates present in small amounts). The developed
approach, therefore, gives insight into not only enzyme levels but
also metabolic flux distributions.
Integration of proteomics
GECKO is well suited for direct integration of proteomics; by setting
each enzyme abundance, we can run simulations with a more
constrained search space. We tested this with an absolute quantita-
tive proteomic dataset of yeast growing at 0.1 h1 aerobically in a
minimal media, limited by glucose (Lahtvee et al, 2017). A total of
453 enzymes were directly matched to our model, accounting for
0.283 g gDW1 in terms of mass, and the appropriate upper bounds
were limited accordingly (including certain flexibility given the
variability of the data). For the other 311 enzymes in the model,
the overall mass constraint previously mentioned was used, limiting
the sum by 0.036 g gDW1, which represents the remaining mass in
the model according to PaxDB (see the Materials and Methods
section). This means that out of all enzyme mass in the model,
88.7% directly matches to experimental values and 11.3% does not.
By including proteomics in the enzyme-constrained model, we
attained a solution with similar exchange fluxes to those predicted
by the purely metabolic model (Appendix Fig S11) and able to
predict with similar performance when compared to flux data quan-
tified by 13C metabolic flux analysis (Jouhten et al, 2008;
Appendix Table S5 and Fig S12). In order to find the main dif-
ferences between both flux distributions, we performed random
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sampling (Bordel et al, 2010) to both models (details of the random
sampling implementation can be found in the Appendix). Out of
4,116 reactions analyzed, 31.7% of them have significantly different
(P < 0.05) flux values between both models, and only 3.7% of them
are both significantly different and have an average difference
higher than 0.1 mmol gDWh1. By performing PCA to all flux
samples, we observed that 37% of the difference between both
model predictions is explained by the first two components
(Fig 5A), which are enriched for pyruvate metabolism, fatty acid
degradation, and glycerophospholipid metabolism.
We further compared both models by performing FVA (refer to
the Appendix for details on the implementation). The analysis
yielded that the predictions of ecYeast7 have a significantly lower
flux variability than the ones of Yeast7 (Fig 5B, P = 1.5e-65 with a
non-parametric Wilcoxon rank-sum test). In particular, only 1.5%
of the variable reactions in ecYeast7 have complete variability, that
is, 1,000 mmol gDWh1, as opposed to the original Yeast7, in
which 25.3% of the variable reactions have this freedom. Out of all
4,972 fluxes in the original model (in irreversible format, for a fair
comparison), 3,177 had their variability reduced by including
enzyme constraints, 1,757 remained the same, and 38 had minor
increases (Appendix Fig S13). Among the 3,177 fluxes with reduced
variability, the mean reduced variability was 87.7%, and 85.4% had
a variability over 90% (Appendix Fig S13B). Overall, by including
enzymatic constraints, we significantly decreased the flux variability
of simulations while maintaining a physiologically relevant
solution.
We also computed the average reduced flux variability by path-
way based on the KEGG pathway classification for each enzyme.
Out of 60 pathways included in the model, the flux variability
decreased in 53 and remained constant in 7. The pathways with
decreased flux variability are spread across metabolism (Fig 5C),
showing that by using enzyme constraints we refined flux predic-
tions for both efficient pathways carrying high fluxes and inefficient
—less utilized—pathways. There is nonetheless a trend to have a
higher flux variability reduction among the most utilized pathways,
that is, carbohydrate and energy primary metabolism, and a lower
flux variability reduction among the least utilized pathways, that is,
intermediate and secondary metabolism. This is evidenced by the
mean log values of each metabolic group (Fig 5C). Finally, by look-
ing into the pathways with the most reduced flux variability, we see
that triglyceride metabolism pathways (glycerolipid and glyc-
erophospholipid metabolism) stand out as the most reduced path-
ways (Fig 5D). This is due to the fact that Yeast7 has a large
amount of triglyceride reactions to represent all possible combina-
tions of fatty acyl triplets; the enzyme limitation thus acts as a
capacity constraint in these scenarios, giving more robust results.
Metabolic engineering applications
Constrained-based modeling techniques such as FBA tend to overes-
timate biological performance under perturbed conditions, for exam-
ple, knockout growth and/or production of a specific metabolite of
interest (Zhang & Hua, 2016). By accounting for enzyme limitations,
the new model should give more realistic predictions under these
scenarios. We evaluated this with a case study: a knockout of NDI1,
a gene that encodes for the mitochondrial NADH dehydrogenase.
Our model was able to capture the shift in the critical specific
growth rate observed in vivo (Luttik et al, 2000; Fig 6A,
Appendix Fig S14), whereas Yeast7 would miss the effect of the
knockout and predict a linear increase in the carbon dioxide produc-
tion rate over the whole range of dilution rates.
We also compared yield predictions of both succinate and farne-
sene of ecYeast7 and Yeast7 to experimental data (Raab et al, 2010;
Otero et al, 2013; Tippmann et al, 2016). As the production envel-
opes show during growth on glucose (Fig 6B and C), using our
enzyme-constrained model reduced the solution space without leav-
ing out feasible biological solutions. During growth on ethanol,
ecYeast7 predicts the same yields for succinate as Yeast7 (Fig 6B),
mainly due to the low ethanol uptake rate. It is interesting to note
that in the case of succinate production, the identified unfeasible
region with the enzyme-constrained model corresponds to mainly
high biomass yield, meaning that succinate itself is not a very
demanding compound in terms of enzyme utilization. This indicates
that classical metabolic engineering approaches are well suited to
increase succinate production, such as knocking out genes and
coupling production to growth (Patil et al, 2005; Raab et al, 2010).
In contrast, in the case of farnesene production, the unfeasible
region corresponds to high farnesene yield, meaning that the farne-
sene production pathway has enzymes with low efficiency. This
suggests that a good approach to improve production of farnesene
would be to perform protein engineering to improve the activity of
enzymes in the corresponding pathway.
As GECKO includes information about enzyme kinetics, it is
possible to calculate the so-called flux control coefficients (FCC)
(Nilsson & Nielsen, 2016). We analyzed the sensitivity of each
enzyme-specific activity on the farnesene specific productivity and
hereby calculated the FCCs associated with farnesene production.
We found that HMG-CoA reductase and farnesene synthase are the
two enzymes with the highest control on farnesene production
(Appendix Fig S15) and therefore should be considered as targets
for overexpression and/or improvement of enzyme activity. Details
on the calculation of FCCs can be found in the Appendix.
Discussion
We have described GECKO, a simple method for constraining meta-
bolic fluxes with enzymatic data that can be implemented for any
GEM. Our method shares elements with previous approaches but
stands out as the first method developed for implementing enzyme
constraints on a genome-scale model using experimentally measured
turnover numbers and enabling the direct integration of absolute
proteomic measurements. GECKO is based on the FBAwMC
approach (Beg et al, 2007) but extended to limit each individual
enzyme, thereby giving a physiologically constrained and thus more
feasible solution. On the other hand, as GECKO uses inequalities
instead of equalities, it is less constrained than RBA (Goelzer et al,
2015), thus relying less on the quality of the experimental data.
Finally, GECKO does not require a detailed description of protein
synthesis, and therefore, its implementation to model eukaryal
organisms is less demanding compared to the ME-modeling strategy
(O’Brien et al, 2013). Furthermore, the resulting enzyme-constrained
models have the same structure as any GEM, such that it can be used
for any constrained-based analysis method (e.g., FBA, FVA, random
sampling), and it can do so in similar computational times compared
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to purely metabolic models, further differentiating them from ME
models, which require larger computational resources.
By applying GECKO to the latest reconstruction of the
yeast consensus metabolic network, we created ecYeast7, an
enzyme-constrained model of S. cerevisiae in which almost half of
the protein mass in yeast is accounted for. By analyzing the
biochemical properties of the accounted enzymes, we showed that
energy and carbon metabolism enzymes are significantly faster and
smaller than the rest of yeast enzymes. This result agrees with
previous observations of kcat values (Bar-Even et al, 2011) and is
intuitive from an evolutionary context, given that key enzymes
should be mass efficient.
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Figure 5. Integration of proteomic data into the model.
A PCA of fluxes from 10,000 random simulations of Yeast7 and 10,000 random simulations of ecYeast7.
B Flux variability for all non-zero variable fluxes from Yeast7 (3,286 reactions, 66.1% of all reactions) and ecYeast7 (3,822 reactions, 56.7% of all reactions).
C Distribution of different pathways in metabolism based on the total usage predicted by ecYeast7 (mg gDW1) and their average flux variability reduction
(mmol gDWh1). The discontinuous lines indicate averages of the log values for different metabolic groups. The light blue filled region highlights the pathways with
the highest average flux variability reduction shown in (D).
D Breakdown of the pathways with the highest average flux variability reduction (mmol gDWh1). Colors correspond to the metabolic groups indicated in (C).
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Using ecYeast7 to simulate physiological behavior, we showed
that overflow metabolism in yeast may be a consequence of a
limited enzyme pool and, ultimately, the energy production
capacity of the cell. This identifies enzyme limitation as a major
driving force behind the reallocation of enzymatic proteins and
the corresponding metabolic fluxes, in agreement with previous
studies (Hui et al, 2015; Nilsson & Nielsen, 2016). This theory
explains not only overflow metabolism but also adaptation under
temperature stress and the maximum specific growth rate for
several carbon sources under different media conditions. There-
fore, our study not only reinforced the hypothesis that efficient
proteome reallocation is an important principle in metabolic regu-
lation but also exhibited how simple physico-chemical constraints
can be integrated with GEMs to improve their predictive power.
Additionally, the enzyme-constrained model proved to be useful
for integrating proteomic data and reducing the intrinsic variabil-
ity of constraint-based simulations. Finally, we showed the poten-
tial of the approach in metabolic engineering applications, such
as reproducing knockout physiology and improving product yield
predictions compared to purely metabolic models. Overall, the
GECKO platform is a fundamental tool for improved simulations
in quantitative computational biology and is highly useful in basic
systems biology for elucidating omics data, and in metabolic engi-
neering for improving the predictive performance of GEMs.
GECKO imposes soft constraints as upper bounds on fluxes,
rather than hard constraints for both upper and lower bounds which
can over-constrain models. However, one could also consider this
as a limitation of the method; by only limiting fluxes with the
enzyme’s maximum capacity, other processes such as regulation of
enzyme activity and under-saturation due to substrate levels are not
accounted for. This indicates that biologically unfeasible solutions
are still in the solution space; that is, the true solution space is even
smaller than the one predicted by ecYeast7. Therefore, a potential
next challenge is to include the aforementioned processes in our
approach, which could explain several other metabolic strategies
(Noor et al, 2016). Metabolite transport/diffusion and protein local-
ization costs could also be accounted for in the future, as recent
work has shown that it can improve constraint-based simulations
(Liu et al, 2014a).
As we have shown, the simulation results of the developed
model largely rely on the choice of kcat values (Appendix Fig S8),
which could have been incorrectly measured and/or incorrectly
annotated. Although it has recently been shown that there is a
good correlation between in vitro kcat measurements from
BRENDA and in vivo values inferred from omics data (Davidi et al,
2016), the future use of this model for specific purposes such as
flux prediction of a given pathway should always involve a prelim-
inary manual curation of the kcat values of the respective pathway.
Furthermore, more detailed kinetic data under different conditions,
ideally at the genome-scale, will be needed in the future for even
more accurate predictions, especially when using this method for
organisms with little kinetic information. Special care should be
taken to, for instance, distinguish how kinetics vary among dif-
ferent isoforms of the same gene, in the case of eukaryal organ-
isms that exhibit splice variants. It is worthy to mention here that
no splice variants are reported for any of the genes in the Yeast7
model.
We envision many possible future uses of the developed
ecYeast7 model. For instance, by overlaying proteomic data, one
could easily compute vmax values, the ultimate constraints on reac-
tions, which otherwise have to be measured individually with
kinetic assays. Additionally, by comparing enzyme measurements
to their usage in the model, we could compute enzyme usage
percentages, which can be interpreted as a new layer of information
connecting proteomics and fluxomics, and can be studied to find
usage trends among different experimental conditions. Moreover,
by having several experimental conditions, we could find enzymes
that are highly used among all conditions, which could be a sign of
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Figure 6. Using the enzyme-constrained model for metabolic engineering applications.
A The physiological response of knocking out NDI1 can be reproduced using ecYeast7. Wild-type and knockout experimental data are shown, together with model
simulations (continuous and segmented lines, respectively).
B Succinate yield (grams of succinate per grams of substrate) versus biomass yield (grams of dry weight biomass per grams of substrate) simulations under batch
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transcriptional regulation. Finally, the developed model could also
be used for testing the effects of varying specific enzyme levels on
the production of a metabolite of interest, modifications that could
be tested in vivo with recently developed techniques for fine-tuning
transcription (Farzadfard et al, 2013).
Materials and Methods
Additional details of GECKO
GECKO uses the flux balance analysis (FBA) approach (Orth et al,
2010). In FBA, the stoichiometry of the cell’s metabolism is repre-
sented in a stoichiometric matrix. The columns of this matrix indi-
cate the stoichiometry of reactions, and the rows indicate mass
balances for each metabolite. By assuming pseudo-steady-state
conditions (i.e., no accumulation), imposing constraints on fluxes
and assuming a cellular objective function, an optimal solution for
all metabolic fluxes can be found. In this study, we further
constrained the solution subspace by limiting fluxes with enzyme
levels. For any enzyme Ei that catalyzes a reaction Rj, it holds true
that:
vj kijcat  ½Ei (1)
where vj is the metabolic flux of Rj (mmol gDWh
1), [Ei] is the
intracellular concentration of Ei, and k
ij
cat is the turnover number of
Ei catalyzing Rj. With GECKO, we impose this constraint on each
reaction in the model (Fig 1). The procedure also accounts for dif-
ferent relationships between enzymes and reactions, as described
in the following:
(i) If the reaction is reversible, two reactions are defined, one in
the forward direction and one in the backward direction, both
utilizing the same enzyme but possibly with specific kcat
values, depending on the enzyme’s substrate affinity.
(ii) In the case of a reaction having isozymes, one reaction for each
enzyme is specified in the model, with different kcat values
based on affinity, when available. Additionally, to keep the
same original upper bound in the reaction’s flux, an “arm reac-
tion” is introduced to constrain the overall flux, creating a
pseudo-metabolite that acts as an intermediate between the
substrates and the products, as previously introduced (Zhang
et al, 2015).
(iii) If an enzyme is promiscuous, then the same enzyme will be
used by all the respective reactions, possibly with different kcat
values (because of different substrates). This implies that there
will be more than one non-zero coefficient in some rows of
the lower left submatrix of the stoichiometric matrix (Fig 1B).
Additionally, because only one enzyme utilization constraint
is defined, the reactions will share the amount of enzyme
available.
(iv) Finally, in the case of a complex, the reaction will utilize all of
the subunits belonging to it. This implies that there will be
more than one non-zero coefficient in some columns of the
lower left submatrix of the stoichiometric matrix (Fig 1B).
Additionally, each subunit’s stoichiometric coefficient in the
reaction will be multiplied by the corresponding subunit’s stoi-
chiometry in the complex.
With these formalisms, complicated constraints (Adadi et al,
2012) are circumvented, and we can directly overlay proteomic
data in the form of an abundance vector on top of the enzymes’
usage in the model. It should be noted that enzymes are not
consumed in our approach, but rather occupied; given that we are
operating under the steady-state assumption, for a fraction of a
second, there is a limited amount of enzyme occupied by its
substrates to catalyze the corresponding flux. Therefore, by impos-
ing a mass constraint on the enzyme level, our framework
prevents reactions from having higher fluxes than that allowed by
the enzyme concentrations.
The developed framework is explained in further detail in the
Appendix, where an example for a toy model is also supplied
(Appendix Fig S1). GECKO is implemented in MATLAB, with a
small section implemented in Python (for querying kcat values from
BRENDA). Both GECKO and ecYeast7 are compatible with the
COBRA toolbox (Schellenberger et al, 2011) or any constraint-based
approach.
Criteria for obtaining kinetic data
All kcat values were automatically retrieved from the BRENDA data-
base (Schomburg et al, 2013). Several criteria were implemented to
properly match each enzyme/reaction pair in the model to its corre-
sponding kcat value (Appendix Table S3). In case of missing data,
certain flexibility was introduced by matching the kcat value to other
substrates, organisms, or even introducing wild cards in the EC
number. In case that more than one value was available, the maxi-
mum kcat value (which corresponds to the fastest working enzyme)
was chosen to avoid over-constraining the model (Nilsson &
Nielsen, 2016). Finally, the kcat values of the main metabolic path-
ways were manually curated with previous data (Nilsson & Nielsen,
2016) and further literature search. Additional information regard-
ing kcat retrieval and matching can be found in the Appendix.
Corrections to the yeast genome-scale model
Several corrections were made to the genome-scale metabolic
model of yeast (Aung et al, 2013) before its use, such as correcting
the glucan coefficients in the biomass pseudo-reaction
(Appendix Table S1), accounting for an extracellular membrane
potential and correcting coefficients in the oxidative phosphoryla-
tion pathway. Energy maintenance was also corrected to improve
predictive performance: The growth associated maintenance (GAM)
without accounting for polymerization costs was refitted to
31 mmol gDWh1 under aerobic conditions based on experimental
data (Van Hoek et al, 1998), and the NGAM was set at
0.7 mmol gDWh1 (Nilsson & Nielsen, 2016). See the Appendix for
more details.
For simulating anaerobic conditions, the oxygen uptake in the
model was blocked and fatty acids and sterols were supplied to
the media. Additionally, heme was removed from the biomass
pseudo-reaction (given that its synthesis requires oxygen and that
it is not needed for anaerobic growth), some reactions’ reversibili-
ties were modified for proper glycerol production, and the growth
associated maintenance was set to 16 mmol gDWh1 without
accounting for polymerization costs. Refer to the Appendix for
additional details.
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Managing the lack of proteomic data
In the absence of proteomic data, we limited the total amount of
enzyme instead of each enzyme separately. To achieve this, we
introduced an additional pseudo-metabolite that represents an
aggregated pool of all enzymes present in the model. This pseudo-
metabolite’s usage has an upper bound equal to the total protein
content Ptotal (g gDW
1) multiplied by a fraction f, which represents
the mass fraction of enzymes that are accounted for in the model
according to PaxDB (Wang et al, 2012) [equal to 0.4461 g (pro-
tein)/g (total cellular protein) in the case of Yeast 7.6], and a param-
eter r representing the average in vivo saturation of all enzymes.
Additionally, we included reactions that draw mass from this pool
toward each enzyme. Hence, a mass balance for the enzyme pool
yields:
XP
i
MWi eir  f  Ptotal (2)
This is similar to a previous approach that accounts for enzyme
limitation (Adadi et al, 2012). When using this formalism, addi-
tional considerations were made, such as adjusting the amino acid
and carbohydrate composition of the biomass according to experi-
mental data (Nissen et al, 1997; Van Hoek et al, 1998), and rescal-
ing the polymerization costs in the growth associated maintenance
(GAM) (details are in the Appendix).
Model analysis
Cytoscape (Cline et al, 2007) was used to display the metabolite
network of the model; metabolites were defined as nodes and an
edge between two nodes was created if both metabolites were
present in the same reaction. The edge thicknesses were set accord-
ing to the number of shared reactions. Pseudo-metabolites created
because of isozymes were not colored. The prefuse force directed
layout algorithm was used for laying out the network.
The enzymes in the model were classified depending on the path-
ways they belong in the KEGG database (Kanehisa & Goto, 2000).
KEGG pathways were classified into one of three metabolic groups
according to a previous classification (Bar-Even et al, 2011;
Appendix Table S2). The intermediate and secondary metabolism
groups were considered just as one metabolic group given how few
secondary metabolism enzymes there were in the model.
Simulation details
Chemostat growth simulations
Chemostat growth was simulated by fixing the specific growth rate
to a given dilution rate, limiting the total enzyme mass to experi-
mental measurements and minimizing the substrate’s uptake rate.
Subsequently, the substrate’s uptake rate was fixed at the obtained
value and the enzyme usage was minimized, similarly to the parsi-
monious FBA procedure (Lewis et al, 2010) but with the enzyme
content. An average enzyme saturation of 46% was used in the case
of CEN-PK113-7D simulations (value fitted to aerobic chemostat
data [Luttik et al, 2000)] and 51% for other strains [value fitted to
aerobic chemostat data of the DS28911 strain (Van Hoek et al,
1998)]. Finally, some exchange reactions such as pyruvate and
acetate exchange were limited to experimental values, and the
reversibility of some NADPH-associated reactions was corrected
based on previous work (Pereira et al, 2016); see the Appendix for
more details.
Batch growth simulations
For simulation of growth in batch cultures, that is, unlimited
substrate availability, no additional constraints aside from the
protein limitation were needed, because during the exponential
phase substrate is available in excess. All experimental data used
were obtained from shake flask cultures from the literature (Tyson &
Lord, 1979; Van Dijken et al, 2000), and oxygen-excess conditions
were assumed. Therefore, unless otherwise stated, the procedure
was to remove any constraint on substrate uptake, change the media
accordingly (either minimal, with amino acids or complex), limit the
total enzyme mass, and parsimoniously maximize biomass. An aver-
age enzyme saturation of 44% was assumed for all batch conditions
(fitted parameter to growth on minimal media with glucose as
carbon source). An upper bound of 2 mmol gDWh1 for the amino
acids and/or nucleotides uptake rates in non-minimal conditions
was imposed. See the Appendix for more details.
Proteomic integration
Absolute proteomic measurements were obtained from a recent study
(Lahtvee et al, 2017). Briefly, S. cerevisiae, strain CEN.PK113-7D,
was grown aerobically in glucose-limited minimal media conditions
at 0.1 h1, in triplicate. The biomass for proteome analyses was
collected within 70 s by centrifuging 2 ml of culture broth at 4°C,
discarding the supernatant and snap-freezing the pellet in liquid
nitrogen. A lysine auxotrophic strain was used to create fully
labeled biomass by feeding labeled heavy 15N, 13C-lysine (Cam-
bridge Isotope Laboratories Inc., Tewksbury, MA, USA), which
was absolutely quantified against the UPS2 protein mix and used
as an internal standard in the proteome analysis.
The samples were digested with 1:50 LysC overnight at room
temperature. Injected peptides (2 lg) were separated on an Ultimate
3000 RSLCnano system (Dionex, Sunnyvale, CA, USA) using a C18
cartridge trap column in a backflush configuration and an in-house
packed (3 lm C18 particles, Dr. Maisch) analytical 50 cm × 75 lm
emitter column (New Objective). Following a LC separation, the
peptides were eluted to a Q Exactive (Thermo Fisher Scientific)
tandem mass spectrometer operating with a top-10 strategy and a
cycle time of 0.9 s. The raw data were identified and quantified with
the MaxQuant 1.4.0.8 software package. The heavy spike-in
standard was quantified with the iBAQ option enabled using log fit
(Schwanha¨usser et al, 2011). The peptide-spectrum match and the
protein false discovery rate (FDR) were maintained below 1% using
a target-decoy approach. All proteomic data and further details on
sample preparation and measurement are available online via
the PRIDE repository (Vizcaı´no et al, 2013), dataset identifier
PXD005041. For this study, values were converted to units of
mmol gDW1, and each enzyme usage in themodel was bounded by:
ei li þ ri (3)
where li is the mean and ri the standard deviation of Ei concentra-
tion among the triplicates. Proteins not detected in 2 or more of
the triplicates were not considered in the analysis. The oxidative
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phosphorylation complexes measurements were corrected to be
proportional to the average relative abundance of all subunits,
given that some subunits were detected in very low amounts.
The measured total protein content was 0.448 g gDW1 (Lahtvee
et al, 2017), from which 0.283 g gDW1 was matched in total to
the model with equation (3). Therefore, equation (2) was used for
the unmeasured enzymes as a constraint with 0.448–0.283 =
0.165 g gDW1 as the amount of enzyme, corrected with
f = 0.2154 g g1 (which represents the abundance of the 311
enzymes in the model from all proteins not matched to the model)
and r = 46%. See the Appendix for more information.
Knockout simulations
The NDI1 (YML120C) knockout in ecYeast7 was simulated by block-
ing the usage of the associated enzyme (P32340). Additionally, both
cytosolic NADH dehydrogenases NDE1 (YMR145C–P40215) and
NDE2 (YDL085W–Q07500) were blocked to simulate the limited
capacity of the ethanol-acetaldehyde shuttle in vivo (Luttik et al,
2000), which is not described in BRENDA. Finally, an average
enzyme saturation of 46% was assumed, given that the strain
CEN.PK113-7D was used in the experimental data source study
(Luttik et al, 2000).
Yield simulations
For the succinate case study, experimental yields from different
strains were gathered from the literature (Raab et al, 2010; Otero
et al, 2013) for growth on glucose and ethanol during batch cultiva-
tions. Glucose and ethanol consumption rates of 8.459 and
0.806 mmol gDWh1, respectively, were assumed [calculated from
the wild-type strain growth (Raab et al, 2010)]. For the farnesene
case, the experimental yields from different strains under fed-batch
growth (Tippmann et al, 2016) were used as validation, and a
glucose consumption rate of 1.228 mmol gDWh1 was assumed
(highest value reported in the study). Additionally, two modifi-
cations were performed in ecYeast7 for the case of farnesene: the
addition of the farnesene synthase from Malus domestica
[Tippmann et al, 2016) (kcat = 0.0553 s
1 according to the literature
(Green et al, 2009)], and the truncation of HMG-CoA reductase to
avoid cleavage to the mitochondrial membrane (Polakowski et al,
1998), which reduces the enzyme weight to 46% of the original
weight.
Both case studies were performed by fixing the specific glucose
uptake rate and maximizing the biomass yield, fixing the specific
growth rate to a suboptimal value and maximizing the correspond-
ing compound production rate, and then fixing the compound
production rate and minimizing enzyme usage. An average enzyme
saturation of 44% was assumed (value for batch conditions).
Data and software availability
The data used in this study and the developed method and model
are all available online:
• Absolute proteomic data: PRIDE PXD005041, “Absolute quan-
tification of yeast proteome” (http://www.ebi.ac.uk/pride/arc
hive/projects/PXD005041; only reference conditions were used)
• GECKO method: GitHub (https://github.com/SysBioChalmers/
GECKO/releases/tag/v1.0)
• ecYeast7 model (both constrained and unconstrained; each as.-
mat,.sbml and.txt files): GitHub (https://github.com/SysBioCha
lmers/GECKO/tree/v1.0/Models)
Expanded View for this article is available online.
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